Lotus Health Group Company / Fundamentals
Income statement
- Net revenue
€368.60M - Cost of goods sold
€266.75M - Gross profit
€101.85M - SG&A expenses
€21.63M - R&D expenses
€3.49M - EBITDA
€48.34M - D&A
€0.00 - EBIT
€44.23M - Interest expenses
€3.38M - EBT
€44.91M - Tax expenses
€13.42M - Net income
€31.84M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€24.64M - Changes in working capital
€0.00 - Operating cash flow
€32.42M - Capex
€32.89M - Other investing cash flow
€21.00M - Net investing cash flow
-€24.84M - Total cash dividends paid
-€4.34M - Issuance of common stock
€0.00 - Debt repayment
€3.55M - Other financing cash flow
-€2.32M - Net financing cash flow
-€3.12M - Foreign exchange effects
€0.00 - Net change in cash
€7.39M - Cash at end of period
€113.28M - Free cash flow
€65.31M
Balance sheet
- Cash and cash equivalents
€157.06M - Cash and short-term investments
€171.29M - Total receivables
€27.34M - Inventory
€22.22M - Other current assets
€32.66M - Total current assets
€253.52M - Property, plant & equipment
€80.51M - Goodwill
€164.59K - Intangible assets
€13.96M - Long-term investments
€0.00 - Other non-current assets
€5.60M - Total non-current assets
€125.08M - Total assets
€378.60M - Accounts payable
€60.90M - Short-term debt
€15.75M - Other current liabilities
€62.60M - Total current liabilities
€144.48M - Long-term debt
€31.21M - Deferred tax liabilities
€294.07K - Other non-current liabilities
€4.53M - Total non-current liabilities
€36.04M - Total liabilities
€180.52M - Common stock
€217.12M - Retained earnings
-€122.83M - Other equity
€0.00 - Total equity
€198.08M - Total liabilities and shareholders' equity
€378.60M
Company information
- Market capitalization
€1.26B - Employees
1.4K - Enterprise Value
€10.09B
Company ratios
- Gross margin
-
27.6% Better than peer group: 17.4% - EBITDA margin
-
13.1% Much worse than peer group: 33.4% - EBIT margin
-
12.0% Worse than peer group: 18.3% - EBT margin
-
12.2% Worse than peer group: 27.1% - Net margin
-
8.6% Worse than peer group: 26.0% - ROE
-
16.1% Better than peer group: 9.6% - ROA
-
8.4% Even with peer group: 3.9% - Asset turnover
-
97.4% Better than peer group: 89.3% - FCF margin
-
-0.1% Better than peer group: -8.8% - FCF yield
-0.0% - Efficiency ratio
86.9% - Net sales per employee
-
€272.03K - Net income per employee
-
€23.50K